Pharmacology
Conference Coverage
Major breakthrough? Average 10% weight loss with semaglutide
“This is impressive data, confirming that semaglutide, particularly when used in concert with evidence-based counseling, is a highly effective...
News
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
“We have supplies to distribute now. Product distribution will begin this week.”
Pharmacology
Continued Dosing of Oritavancin for Complicated Gram-Positive Infections
Several retrospective and cohort analyses have suggested that continued dosing of oritavancin is both safe and efficacious for Gram-positive...
Original Research
The Effect of Radium-223 Therapy in Agent Orange-Related Prostate Carcinoma
Radium-223 radioisotope has been reported to increase median survival in bone metastatic prostate carcinoma; however, there have been no...
Conference Coverage
Choosing pharmacotherapy for bipolar disorder requires a risk-benefit analysis
Some patients with bipolar disorder may demonstrate symptoms of anxiety that aren’t part of the DSM-5 criteria for an anxiety disorder, said Dr....
News
How cannabis-based therapeutics could help fight COVID inflammation
The race to find an effective treatment for COVID-19 continues.
Conference Coverage
Sublingual apomorphine alleviates off episodes in Parkinson’s disease
The sublingual film had more oral adverse effects than the injectable drug, but it may have advantages over subcutaneous apomorphine injections in...
Conference Coverage
Biologics may protect psoriasis patients against severe COVID-19
Preliminary evidence suggests biologics prevent the fearsome COVID-19 late cytokine storm.
News
Two COVID-19 outpatient antibody drugs show encouraging results
News
Real-world results with checkpoint inhibitors found inferior to trial results
Data suggest real-world survival is worse than survival in clinical trials.